Cancer name Pancreatic Cancer
Cancer Type PAAD
Immunotherapy type Adoptive Cell Therapy
Treatment telomerase peptide GV1003
Drugstatus NA
Drugbank ID NA
Checkpoints NA
Signature Type Protein
Signature Human telomerase reverse transcriptase (hTERT)
Official Symbol NA
Mode of action PROT_D_UP
Description for ‘mode of action’:the ‘mode of action’ for signature is composed of three parts: A_B_C. A describes the level at which the corresponding signature changes, it may contain the following values: TRAN(translation), PROT(protein), CE(cell), METH(methylation), AC(acetylation), PHOS(phosphorylation), MU(mutation), SNP(single nucleotide polymorphism), GLYC(glycosylation) and PATH(pathway). B describes the corresponding signature in which cancer immunotherapy condition group has changed, it may contain the following values: R (immunotherapy response group), NR(immunotherapy non-response group), D (Immunotherapy group), ND (No immunotherapy group). C describes the change detail (specific direction) of the corresponding signature, it may contain the following values: UP (High gene/protein expression or increased cellular abundance or enhanced epigenetic modification), DN (Low gene/protein expression or reduced cellular abundance or attenuated epigenetic modifications), LOSS (deletion mutation), GAIN (gain mutation),Other. For example, the search/browse detail result for CD274 was “PROT_R_UP”, it can be interpreted that the protein level of CD274 was upregulated in immunotherapy response individuals.
Experimental clinical trail
Description Human telomerase reverse transcriptase (hTERT) is overexpressed in most human cancers and thus a widely applicable target for cancer therapy
PMID 28123886
Title T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy